MDPI and ACS Style
Schneeweiss-Gleixner, M.; Filik, Y.; Stefanzl, G.; Berger, D.; Sadovnik, I.; Bauer, K.; Smiljkovic, D.; Eisenwort, G.; Witzeneder, N.; Greiner, G.;
et al. CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V+ Neoplastic Mast Cells. Cancers 2022, 14, 3070.
https://doi.org/10.3390/cancers14133070
AMA Style
Schneeweiss-Gleixner M, Filik Y, Stefanzl G, Berger D, Sadovnik I, Bauer K, Smiljkovic D, Eisenwort G, Witzeneder N, Greiner G,
et al. CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V+ Neoplastic Mast Cells. Cancers. 2022; 14(13):3070.
https://doi.org/10.3390/cancers14133070
Chicago/Turabian Style
Schneeweiss-Gleixner, Mathias, Yüksel Filik, Gabriele Stefanzl, Daniela Berger, Irina Sadovnik, Karin Bauer, Dubravka Smiljkovic, Gregor Eisenwort, Nadine Witzeneder, Georg Greiner,
and et al. 2022. "CDK4/CDK6 Inhibitors Synergize with Midostaurin, Avapritinib, and Nintedanib in Inducing Growth Inhibition in KIT D816V+ Neoplastic Mast Cells" Cancers 14, no. 13: 3070.
https://doi.org/10.3390/cancers14133070